CHARLOTTESVILLE, Va., Aug. 15, 2023 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) today announced that its stockholders have voted to approve all proposals at a special meeting of ...
This package is developed and tested under Python 3.9.x. The primary Python packages and their versions are as follows. For more details, please refer to the environment.yaml file. # fetch and extract ...
Diffusion Pharmaceuticals Inc. today announced topline results from the Company’s Phase 1 trial of its lead product candidate, trans sodium crocetinate (“TSC”). CHARLOTTESVILLE, Va., June 30, 2021 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results